Clinical Trials in Illinois

Showing 6861-6880 of 19,692 trials

Safety, Tolerability, and Efficacy Study of UBX1325 in Patients With Neovascular Age-Related Macular Degeneration (ENVISION)

NCT05275205

This study is intended to assess safety, tolerability and biological activity of a repeat IVT injection of UBX1325 in patients with wet AMD.

Neovascular Age-related Macular Degeneration

Unity Biotechnology, Inc.51 participantsStarted Mar 2022

Beverly Hills, California, United States • Huntington Beach, California, United States • Longmont, Colorado, United States +11 more locations

COMPLETEDPhase 140 miles

A Dose Escalation Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1345 in Healthy Adults and in Children Who Are Respiratory Syncytial Virus (RSV)-Seropositive

NCT04528719

The primary objectives of this study are to evaluate the tolerability and reactogenicity of a single injection of up to 5 dose levels of mRNA-1345 in younger adults, women of child-bearing potential, and older adults including Japanese older adults; of 3 injections of the middle dose level of mRNA-1345 given 56 days apart in younger adults; of a booster injection of mRNA-1345 given approximately 12 and 24 months after the primary injection in older adults; and of 3 injections of 1 of 2 dose levels of mRNA-1345 given 56 days apart in children who are RSV-seropositive.

Respiratory Syncytial Virus

ModernaTX, Inc.651 participantsStarted Sep 2020

La Mesa, California, United States • West Hollywood, California, United States • DeLand, Florida, United States +28 more locations

Safety, Tolerability, and Efficacy Study of UBX1325 in Patients With Neovascular Age-Related Macular Degeneration (ENVISION)

A Dose Escalation Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1345 in Healthy Adults and in Children Who Are Respiratory Syncytial Virus (RSV)-Seropositive

Find Trials by Condition in Illinois

Hypertrophic Cardiomyopathy Federated Learning Implementation Platform

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH CD3-OLS)

A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression

Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease

Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)

HAART Annuloplasty Device Valve Repair Registry

Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma

Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple Myeloma

A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors

Four Arm Safety & Efficacy With Antipyrine and Benzocaine Otic Solution in Children With Acute Otitis Media

Efficacy and Safety of Vibrant Capsule vs. Placebo for the Treatment of Chronic Idiopathic Constipation

An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa

An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma

MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL)

Training for Health Professionals In Tanzania

A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)

Optina Diagnostics' Cerebral ß-Amyloid Status (CAS) Test

Project Health: Enhancing Effectiveness of a Dissonance-Based Obesity Prevention Program